BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND PR, PGR, progesterone receptor
2266 results:

  • 1. Glycometabolism and lipid metabolism related genes predict the prognosis of endometrial carcinoma and their effects on tumor cells.
    Lin X; Zheng J; Cai X; Liu L; Jiang S; Liu Q; Sun Y
    BMC Cancer; 2024 May; 24(1):571. PubMed ID: 38720279
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Sexual Orientation and Cervical cancer Screening Among Cisgender Women.
    Baumann K; Matzke H; Peterson CE; Geller S; Flores R; Prachand NG; Holt HK
    JAMA Netw Open; 2024 May; 7(5):e248886. PubMed ID: 38709536
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Protective effect of quercetin on lipopolysaccharide‑induced miscarriage based on animal experiments and network pharmacology.
    Wu S; Tian Y; Zhang Q; Fu Z; Lan H; Zhou X; Ma L; Lou Y
    Mol Med Rep; 2024 Jun; 29(6):. PubMed ID: 38606505
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Real-life efficacy and safety of cemiplimab in advanced cervical cancer from a nominal use program in Italy: The MITO 44 study.
    Tuninetti V; Virano E; Salutari V; Ricotti A; Pisano C; Ducceschi M; Turitto G; Scandurra G; Petrella MC; Forestieri V; Rizzetto M; Mammoliti S; Artioli G; Cioffi R; Borsotti L; Bellero M; Rognone C; Carbone V; Ferrandina G; Mantiero M; Azzolina C; Geninatti E; Pignata S; Valabrega G
    Eur J Cancer; 2024 May; 203():114039. PubMed ID: 38598922
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Human Papillomavirus Vaccine Awareness and Acceptability for Primary Prevention of Cervical cancer in Pakistan: A Cross-Sectional Study.
    Shamsi U; Zahid F; Abdul Jabbar AB; Musharraf MD; Gauhar F; Akbar I; Sherwani M; Bhatti WK; Chaudhary EUH; Sadiq S; Shaikh AN; Shaikh F
    Asian Pac J Cancer Prev; 2024 Mar; 25(3):813-820. PubMed ID: 38546064
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Expanding the Spectrum of NR4A3 Fusion-Positive Gynecologic Leiomyosarcomas.
    Momeni-Boroujeni A; Mullaney K; DiNapoli SE; Leitao MM; Hensley ML; Katabi N; Allison DHR; Park KJ; Antonescu CR; Chiang S
    Mod Pathol; 2024 May; 37(5):100474. PubMed ID: 38508521
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Impaired fertility in adenomyosis: a murine model reveals endometrial receptivity and progesterone resistance imbalances.
    Squatrito M; Vervier J; Bindels J; Bernet L; Blacher S; Nisolle M; Munaut C
    Reproduction; 2024 May; 167(5):. PubMed ID: 38451875
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. To study the expression of estrogen, progesterone receptor and p53 immunohistochemistry markers in subtyping endometrial carcinoma.
    Yadav A; Sistla A; Swain M; Gowrishankar S; Padua M; Modi T; Himabindu R; Agarwal N; Kulkarni A; Bhandari T; Vudayaraju H; Chinnababu ; Reddy VA
    Indian J Pathol Microbiol; 2024; 67(1):62-67. PubMed ID: 38358190
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Trichorhinophalangeal Syndrome Type 1 Immunohistochemical Expression in Carcinomas of Gynecologic Origin.
    Ruiz F; Tjendra Y; Millan N; Gomez-Fernandez C; Pinto A
    Am J Surg Pathol; 2024 May; 48(5):546-550. PubMed ID: 38357982
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Factors associated with utilization of cervical cancer screening services among HIV-positive women aged 18 to 49 years at Lira regional referral hospital, Northern Uganda.
    Layet F; Murungi T; Ashaba N; Kigongo E; Opollo MS
    BMC Womens Health; 2024 Feb; 24(1):114. PubMed ID: 38347497
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The management of uterine tumor resembling an ovarian sex cord tumor (UTROSCT): case series and literature review.
    Lin J; Liu L; Wang L; Ma N; Zhang K; Xie N; Yu H; Deng S; Sun Y
    World J Surg Oncol; 2024 Feb; 22(1):42. PubMed ID: 38310233
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Rare germline mutation and MSH2-&MSH6 + expression in a double primary carcinoma of colorectal carcinoma and endometrial carcinoma: a case report.
    Zhang T; Huang X; Liu W; Ling X; Su Z; Huang M; Che S
    Diagn Pathol; 2024 Jan; 19(1):25. PubMed ID: 38297350
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. A phase I study of Mirvetuximab Soravtansine and gemcitabine in patients with FRα-positive recurrent ovarian, primary peritoneal, fallopian tube, or endometrial cancer, or triple negative breast cancer.
    Cristea MC; Stewart D; Synold T; Ruel N; Mortimer J; Wang E; Jung A; Wilczynski S; Konecny GE; Eng M; Kilpatrick L; Han E; Dellinger T; Hakim A; Lee S; Morgan RJ; Wakabayashi MT; Frankel PH
    Gynecol Oncol; 2024 Mar; 182():124-131. PubMed ID: 38262235
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The comparison of pure uterine serous carcinoma and mixed tumor with serous component: a single-institution review of 91 cases.
    You X; Dong Y; Wang J; Cheng Y; Jia Y; Zhang X; Wang J
    BMC Cancer; 2024 Jan; 24(1):99. PubMed ID: 38233757
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Impact of estrogen and progesterone receptor expression on the incidence of endometrial polyps.
    Yan C; Xing C; Wei T; Zhou H; Wang H; Liu T; Gao J
    Biomark Med; 2023 Nov; 17(21):881-887. PubMed ID: 38230984
    [No Abstract]    [Full Text] [Related]  

  • 16. Whether specific genetic feature predicted immunotherapy efficacy: A case report.
    Chen J; Pang L; He L; Li T; Cheng X
    Medicine (Baltimore); 2024 Jan; 103(2):e36922. PubMed ID: 38215117
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Predictive and prognostic biomarkers in female genital tract tumours: an update highlighting their clinical relevance and practical issues.
    Wong RW; Cheung ANY
    Pathology; 2024 Mar; 56(2):214-227. PubMed ID: 38212229
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Association between Serum Folate and Vaginal High-Risk Human Papillomavirus Infections in United States Women.
    Peitz JG; Adebamowo CA; Adebamowo SN
    J Nutr; 2024 Feb; 154(2):583-589. PubMed ID: 38158185
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Oncologic, fertility, and obstetric outcomes with MPA therapy in women with endometrial cancer and atypical endometrial hyperplasia.
    Takeda A; Yamamoto Y; Tamura K; Aoki H; Noguchi H; Minato S; Kamada S; Arakaki R; Kaji T; Iwasa T
    J Obstet Gynaecol Res; 2024 Apr; 50(4):633-638. PubMed ID: 38154145
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Cervical cancer screening in Brazilian Amazon Indigenous women: Towards the intensification of public policies for prevention.
    Novais IR; Coelho CO; Machado HC; Surita F; Zeferino LC; Vale DB
    PLoS One; 2023; 18(12):e0294956. PubMed ID: 38064494
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 114.